Skip links
Companies
› China › Vcanbio Cell & Gene Engineering Corp., Ltd
Company registry profile

Vcanbio Cell & Gene Engineering Corp., Ltd

Active

From the registry

Registration details

Incorporation Date
Not disclosed
Company Type
Not disclosed
Address
Tianjin, China
Website
www.vcanbio.com/
Status
Active
Country
China
Source: SAMR — public search via GSXT (National Enterprise Credit Information Publicity System)Registry coverage
Registry summary

Company overview

Vcanbio Cell & Gene Engineering Corp., Ltd is a registered legal entity registered in China, and its current status with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) is active. Its registered address on file is Tianjin, China. 1 shareholder is on record for Vcanbio Cell & Gene Engineering Corp., Ltd, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) and was last updated on 22 September 2026.

Data Provenance
This record is sourced directly from official government registries, including SAMR — public search via GSXT (National Enterprise Credit Information Publicity System).

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

1

Shareholders of Vcanbio Cell & Gene Engineering Corp., Ltd

One shareholder is currently on record for Vcanbio Cell & Gene Engineering Corp., Ltd, held on the capital contribution filing on the National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), filed under the Company Law of the PRC. The largest of these is Vanguard International Stock Index-Emerging Markets Stk, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Swipe or scroll for more columns

Shareholder Type Holding Source Document
Vanguard International Stock Index-Emerging Markets Stk 100% SAMR — public search via GSXT (National Enterprise Credit Information Publicity System)

Officers

5

Directors and officers of Vcanbio Cell & Gene Engineering Corp., Ltd

The Vice Chairman & Gm of Vcanbio Cell & Gene Engineering Corp., Ltd currently on record is Hongqi Wang; five officers are currently on record for Vcanbio Cell & Gene Engineering Corp., Ltd, filed with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System). Management authority at Vcanbio Cell & Gene Engineering Corp., Ltd sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control. The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

Data availability

The register reports 10 officers in total, including past appointments, though only the 5 most relevant records are shown here.

HW
Hongqi Wang ACTIVE

Residence
🇨🇳 China
Occupation
Vice Chairman & Gm

YW
Yueming Wang ACTIVE

Residence
🇨🇳 China
Occupation
Chief Human Resources Officer

XL
Xu Li ACTIVE

Residence
🇨🇳 China
Occupation
Deputy Gm & Director

HX
Hong Xiang Shi ACTIVE

Residence
🇨🇳 China
Occupation
Deputy General Manager

XZ
Xin Zhe Yang ACTIVE

Residence
🇨🇳 China
Occupation
Deputy Gm & Secretary

Registry questions

Frequently asked questions

Who owns Vcanbio Cell & Gene Engineering Corp., Ltd?

One shareholder is currently on record for Vcanbio Cell & Gene Engineering Corp., Ltd, held on the capital contribution filing on the National Enterprise Credit Information Publicity System (国家企业信用信息公示系统), filed under the Company Law of the PRC. The largest of these is Vanguard International Stock Index-Emerging Markets Stk, holding 100% — a majority holding. Because the shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.

Who is Vcanbio Cell & Gene Engineering Corp., Ltd's UBO (Ultimate Beneficial Owner)?

Every shareholder recorded for Vcanbio Cell & Gene Engineering Corp., Ltd is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.

How many shareholders does Vcanbio Cell & Gene Engineering Corp., Ltd have on record?

1 shareholder is shown on record for Vcanbio Cell & Gene Engineering Corp., Ltd.

Is Vcanbio Cell & Gene Engineering Corp., Ltd still an active company?

Vcanbio Cell & Gene Engineering Corp., Ltd's status on SAMR — public search via GSXT (National Enterprise Credit Information Publicity System) is listed as active.

What is Vcanbio Cell & Gene Engineering Corp., Ltd's registered address?

The registered address on file for Vcanbio Cell & Gene Engineering Corp., Ltd is Tianjin, China.

Who are the officers/directors of Vcanbio Cell & Gene Engineering Corp., Ltd?

The Vice Chairman & Gm of Vcanbio Cell & Gene Engineering Corp., Ltd currently on record is Hongqi Wang; five officers are currently on record for Vcanbio Cell & Gene Engineering Corp., Ltd, filed with SAMR — public search via GSXT (National Enterprise Credit Information Publicity System). Management authority at Vcanbio Cell & Gene Engineering Corp., Ltd sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Other companies in China · Healthcare

All companies in China · Human Health and Social Work Activities in China

This website uses cookies to improve your web experience.